Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case-control study.
Kellie J GoodletSofya TokmanAasya NasarLauren CherrierRajat WaliaMichael D NailorPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Trimethoprim/sulfamethoxazole prophylaxis was shown to be protective against nocardiosis in lung transplant recipients, while augmented immunosuppression conferred increased risk. Institutional epidemiologic data are needed to best guide empiric therapy for Nocardia, as historical in vitro data may not predict local susceptibilities.